Akoya Biosciences Marks Milestone Achievement with Shipment of 1,000th Spatial Biology Instrument
27 avr. 2023 08h00 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., April 27, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced it has shipped it’s 1,000th instrument, a...
Akoya Biosciences and Enable Medicine Introduce Cloud Platform to Power Faster Analysis of PhenoCycler-Fusion Data
12 avr. 2023 08h00 HE
|
Akoya Biosciences, Inc.
Enable Cloud Platform trained on high plex spatial imaging datasets across 20,000 samples run on the PhenoCycler® SystemCommercial launch at AACR 2023 Annual Meeting (Akoya booth #1713) ...
Akoya Biosciences Introduces PhenoCode Discovery Panels to Simplify PhenoCycler-Fusion Workflow
12 avr. 2023 08h00 HE
|
Akoya Biosciences, Inc.
Modular panel design sets foundation for continued expansion of applications on the PhenoCycler®-Fusion systemFirst protein panel commercially available at AACR 2023 Annual Meeting and first RNA panel...
Akoya to Report First Quarter 2023 Financial Results on May 8th, 2023
06 avr. 2023 08h00 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., April 06, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the...
Akoya Biosciences Announces Leadership Transition
20 mars 2023 16h00 HE
|
Akoya Biosciences, Inc.
Joe Driscoll to Retire After More than Four Successful Years as Chief Financial Officer Johnny Ek Appointed as new Chief Financial Officer MARLBOROUGH, Mass., March 20, 2023 (GLOBE NEWSWIRE) --...
Akoya Reports Record Revenue in the Fourth Quarter of 2022 and Provides Full Year 2023 Revenue Guidance
06 mars 2023 16h05 HE
|
Akoya Biosciences, Inc.
Q4 2022 revenue $21.2 million and FY 2022 revenue $74.9 millionFY 2023 revenue guidance range $95-98 million MARLBOROUGH, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc....
Akoya Biosciences Announces Appointment of Jennifer Kamocsay as General Counsel
28 févr. 2023 08h00 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Jennifer Kamocsay as General...
Akoya to Report Fourth Quarter and Full Year 2022 Financial Results on March 6th, 2023 and Participate at Two Upcoming Investor Conferences
06 févr. 2023 08h05 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the...
Akoya Biosciences to Present First-of-its-Kind Spatial Multiomics Dataset at 2023 AGBT General Meeting
01 févr. 2023 08h00 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that the company will present results from a...
Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2022
08 janv. 2023 16h00 HE
|
Akoya Biosciences, Inc.
MARLBOROUGH, Mass., Jan. 08, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced preliminary unaudited revenue for the fourth...